Sitagliptin reduces FAP-activity and increases intact FGF21 levels in patients with newly detected glucose abnormalities
| Autor: | Pedersen, Anne K.N., Hage, Camilla, Jessen, Niels, Mellbin, Linda, Bjerre, Mette |
|---|---|
| Zdroj: | In Molecular and Cellular Endocrinology 1 October 2022 556 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect